PL369732A1 - Pochodne benzoksazyny i benzotiazyny oraz kompozycje farmaceutyczne je zawierające - Google Patents

Pochodne benzoksazyny i benzotiazyny oraz kompozycje farmaceutyczne je zawierające

Info

Publication number: PL369732A1
Authority: PL; Poland
Prior art keywords: benzoxazine; pharmaceutical compositions; compositions containing; benzothiazine derivatives; benzothiazine
Prior art date: 2001-10-16

Application number

PL02369732A

Other languages

English (en)

Inventor

Debnath Bhuniya

Saibal Kumar Das

Gurram Ranga Madhavan

Javed Iqbal

Ranjan Chakrabarti

Original Assignee

Dr.Reddy's Laboratories Ltd.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-10-16

Filing date

2002-10-15

Publication date

2005-05-02

2002-10-15 Application filed by Dr.Reddy's Laboratories Ltd. filed Critical Dr.Reddy's Laboratories Ltd.

2005-05-02 Publication of PL369732A1 publication Critical patent/PL369732A1/pl

Links

UJVBZCCNLAAMOV-UHFFFAOYSA-N 2h-1,2-benzothiazine Chemical class C1=CC=C2C=CNSC2=C1 UJVBZCCNLAAMOV-UHFFFAOYSA-N 0.000 title 1
CMLFRMDBDNHMRA-UHFFFAOYSA-N 2h-1,2-benzoxazine Chemical compound C1=CC=C2C=CNOC2=C1 CMLFRMDBDNHMRA-UHFFFAOYSA-N 0.000 title 1
239000008194 pharmaceutical composition Substances 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/40—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/42—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton with carboxyl groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by saturated carbon chains
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/34—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
- C07D265/36—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
- C07D279/14—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
- C07D279/16—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Diabetes (AREA)
Physical Education & Sports Medicine (AREA)
Orthopedic Medicine & Surgery (AREA)
Obesity (AREA)
Hematology (AREA)
Neurology (AREA)
Rheumatology (AREA)
Urology & Nephrology (AREA)
Cardiology (AREA)
Endocrinology (AREA)
Heart & Thoracic Surgery (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Nutrition Science (AREA)
Hospice & Palliative Care (AREA)
Child & Adolescent Psychology (AREA)
Psychiatry (AREA)
Dermatology (AREA)
Vascular Medicine (AREA)
Pain & Pain Management (AREA)
Emergency Medicine (AREA)
Reproductive Health (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

PL02369732A 2001-10-16 2002-10-15 Pochodne benzoksazyny i benzotiazyny oraz kompozycje farmaceutyczne je zawierające PL369732A1 (pl)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
IN848CH2001		2001-10-16

Publications (1)

Publication Number	Publication Date
PL369732A1 true PL369732A1 (pl)	2005-05-02

Family

ID=11097010

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
PL02369732A PL369732A1 (pl)	2001-10-16	2002-10-15	Pochodne benzoksazyny i benzotiazyny oraz kompozycje farmaceutyczne je zawierające
PL02369655A PL369655A1 (pl)	2001-10-16	2002-10-15	Nowe beta-fenylo-alfa-oksypodstawione pochodne kwasu propionowego, sposób ich wytwarzania oraz ich zastosowanie do otrzymywania farmaceutycznie istotnych związków

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
PL02369655A PL369655A1 (pl)	2001-10-16	2002-10-15	Nowe beta-fenylo-alfa-oksypodstawione pochodne kwasu propionowego, sposób ich wytwarzania oraz ich zastosowanie do otrzymywania farmaceutycznie istotnych związków

Country Status (14)

Country	Link
US (2)	US20110105748A1 (pl)
EP (2)	EP1436247A1 (pl)
JP (2)	JP2005527480A (pl)
CN (2)	CN1596249A (pl)
BR (2)	BR0213350A (pl)
CA (2)	CA2463686A1 (pl)
HR (2)	HRP20040350A2 (pl)
HU (2)	HUP0401649A3 (pl)
IL (2)	IL161429A0 (pl)
NO (2)	NO20041994L (pl)
NZ (1)	NZ532285A (pl)
PL (2)	PL369732A1 (pl)
WO (2)	WO2003033481A1 (pl)
ZA (2)	ZA200402858B (pl)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2005040102A2 (en) *	2003-10-28	2005-05-06	Dr. Reddy's Laboratories Ltd.	Novel compounds and their use as antidiabetic and hypolipidemic agents, process for their preparation and pharmaceutical compositions containing them
EP1734963A4 (en)	2004-04-02	2008-06-18	Merck & Co Inc	METHOD FOR TREATING PEOPLE WITH METABOLIC AND ANTHROPOMETRIC DISORDER
ITRM20050389A1 (it)	2005-07-22	2007-01-23	Giuliani Spa	Composti e loro sali specifici per i recettori ppar ed i recettori per l'egf e loro uso in campo medico.
ITRM20050390A1 (it)	2005-07-22	2007-01-23	Giuliani Spa	Composti e loro sali specifici per i recettori ppar ed i recettori per l'egf e loro uso in campo medico.
US7749995B2 (en) *	2006-05-11	2010-07-06	Janssen Pharmaceutica Nv	3,4-dihydro-2h-benzo[1,4]oxazine and thiazine derivatives as CETP inhibitors
EP2034998A1 (en)	2006-05-11	2009-03-18	Janssen Pharmaceutica, N.V.	1,2,3,4-tetrahydro-quinoline derivatives as cetp inhibitors
CN105250285B (zh) *	2007-04-11	2019-09-06	奥默罗斯公司	预防和治疗成瘾的组合物和方法
US20160331729A9 (en)	2007-04-11	2016-11-17	Omeros Corporation	Compositions and methods for prophylaxis and treatment of addictions
US11241420B2 (en)	2007-04-11	2022-02-08	Omeros Corporation	Compositions and methods for prophylaxis and treatment of addictions
US8969514B2 (en)	2007-06-04	2015-03-03	Synergy Pharmaceuticals, Inc.	Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
MX354786B (es)	2007-06-04	2018-03-21	Synergy Pharmaceuticals Inc	Agonistas de guanilato ciclasa utiles para el tratamiento de trastornos gastrointestinales, inflamacion, cancer y otros trastornos.
CA2726917C (en)	2008-06-04	2018-06-26	Synergy Pharmaceuticals Inc.	Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
EP2321341B1 (en)	2008-07-16	2017-02-22	Synergy Pharmaceuticals Inc.	Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
US8410284B2 (en)	2008-10-22	2013-04-02	Merck Sharp & Dohme Corp	Cyclic benzimidazole derivatives useful as anti-diabetic agents
CA2741672A1 (en)	2008-10-31	2010-05-06	Merck Sharp & Dohme Corp.	Novel cyclic benzimidazole derivatives useful anti-diabetic agents
UA107562C2 (uk)	2008-12-05	2015-01-26		Спосіб лікування псоріазу
HRP20170936T1 (hr)	2009-02-16	2017-09-22	Nogra Pharma Limited	Alkilamido spojevi i njihova uporaba
AU2011218830B2 (en)	2010-02-25	2014-07-24	Merck Sharp & Dohme Corp.	Novel cyclic benzimidazole derivatives useful anti-diabetic agents
AU2011254726B2 (en)	2010-05-19	2014-03-06	Upfield Europe B.V.	Theobromine for increasing HDL-cholesterol
WO2012027331A1 (en)	2010-08-27	2012-03-01	Ironwood Pharmaceuticals, Inc.	Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders
US9616097B2 (en)	2010-09-15	2017-04-11	Synergy Pharmaceuticals, Inc.	Formulations of guanylate cyclase C agonists and methods of use
CA2826649C (en)	2011-02-25	2016-07-26	Merck Sharp & Dohme Corp.	Novel cyclic azabenzimidazole derivatives useful as anti-diabetic agents
US20150004144A1 (en)	2011-12-02	2015-01-01	The General Hospital Corporation	Differentiation into brown adipocytes
WO2013117744A2 (en)	2012-02-09	2013-08-15	Nogra Pharma Limited	Methods of treating fibrosis
NZ631049A (en)	2012-04-18	2017-02-24	Nogra Pharma Ltd	Methods of treating lactose intolerance
RU2015106909A (ru)	2012-08-02	2016-09-27	Мерк Шарп И Доум Корп.	Антидиабетические трициклические соединения
BR112015019836A2 (pt)	2013-02-22	2017-07-18	Merck Sharp & Dohme	composto, composição farmacêutica, e, uso de um composto
EP2970119B1 (en)	2013-03-14	2021-11-03	Merck Sharp & Dohme Corp.	Novel indole derivatives useful as anti-diabetic agents
WO2014151200A2 (en)	2013-03-15	2014-09-25	Synergy Pharmaceuticals Inc.	Compositions useful for the treatment of gastrointestinal disorders
JP2016514671A (ja)	2013-03-15	2016-05-23	シナジーファーマシューティカルズインコーポレイテッド	グアニル酸シクラーゼのアゴニストおよびその使用
KR20160003641A (ko) *	2013-04-30	2016-01-11	쓰리엠 이노베이티브 프로퍼티즈 컴파니	폴리(벤족사진)의 제조 방법
CN105764916B (zh)	2013-06-05	2021-05-18	博士医疗爱尔兰有限公司	鸟苷酸环化酶c的超纯激动剂、制备和使用所述激动剂的方法
WO2015051496A1 (en)	2013-10-08	2015-04-16	Merck Sharp & Dohme Corp.	Antidiabetic tricyclic compounds
PT3166923T (pt)	2014-07-10	2023-06-02	SpecGx LLC	Processo para preparar fenilalcanos substituídos
US11072602B2 (en)	2016-12-06	2021-07-27	Merck Sharp & Dohme Corp.	Antidiabetic heterocyclic compounds
WO2018118670A1 (en)	2016-12-20	2018-06-28	Merck Sharp & Dohme Corp.	Antidiabetic spirochroman compounds
AU2020217884B2 (en) *	2019-02-08	2025-02-20	Nogra Pharma Limited	Process of making 3-(4'-aminophenyl)-2-methoxypropionic acid, and analogs and intermediates thereof
CN113968781A (zh) *	2021-11-11	2022-01-25	上海吉奉生物科技有限公司	一种(s)-2-羟基-3-邻甲基丙酸的合成方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1996028405A1 (fr) *	1995-03-10	1996-09-19	Nitto Chemical Industry Co., Ltd.	Procede de production de derives de 1,2-ethanediol
NZ504106A (en)	1998-05-27	2003-02-28	Dr	Fused Oxazine, Thiazine and pipyridine compounds, process for their preparation and pharmaceutical compositions containing them
EP1175412A1 (en)	1999-04-28	2002-01-30	Dr. Reddy's Research Foundation	Substituted bicyclic heterocycles, process for their preparation and their use as antiobesity and hypocholesterolemic agents
SE9904421D0 (sv) *	1999-12-03	1999-12-03	Astra Ab	New compounds
WO2002030914A1 (en) *	2000-10-12	2002-04-18	Dr. Reddy's Research Foundation	Salts of benzothiazine and benzoxazine derivatives and pharmaceutical compositions containing them

2002
- 2002-10-15 PL PL02369732A patent/PL369732A1/pl not_active Application Discontinuation
- 2002-10-15 IL IL16142902A patent/IL161429A0/xx unknown
- 2002-10-15 JP JP2003536221A patent/JP2005527480A/ja not_active Withdrawn
- 2002-10-15 PL PL02369655A patent/PL369655A1/pl not_active Application Discontinuation
- 2002-10-15 WO PCT/IB2002/004275 patent/WO2003033481A1/en not_active Ceased
- 2002-10-15 BR BR0213350-4A patent/BR0213350A/pt not_active IP Right Cessation
- 2002-10-15 JP JP2003536197A patent/JP2005505617A/ja active Pending
- 2002-10-15 CN CNA028238222A patent/CN1596249A/zh active Pending
- 2002-10-15 CA CA002463686A patent/CA2463686A1/en not_active Abandoned
- 2002-10-15 CA CA002463685A patent/CA2463685A1/en not_active Abandoned
- 2002-10-15 EP EP02801466A patent/EP1436247A1/en not_active Withdrawn
- 2002-10-15 HU HU0401649A patent/HUP0401649A3/hu unknown
- 2002-10-15 NZ NZ532285A patent/NZ532285A/en unknown
- 2002-10-15 WO PCT/IB2002/004274 patent/WO2003033456A1/en not_active Ceased
- 2002-10-15 HR HR20040350A patent/HRP20040350A2/xx not_active Application Discontinuation
- 2002-10-15 CN CNA028227239A patent/CN1589258A/zh active Pending
- 2002-10-15 US US10/492,452 patent/US20110105748A1/en not_active Abandoned
- 2002-10-15 EP EP02775090A patent/EP1436268A1/en not_active Withdrawn
- 2002-10-15 BR BR0213380-6A patent/BR0213380A/pt not_active Application Discontinuation
- 2002-10-15 US US10/492,454 patent/US7365064B2/en not_active Expired - Fee Related
- 2002-10-15 IL IL16143102A patent/IL161431A0/xx unknown
- 2002-10-15 HR HR20040349A patent/HRP20040349A2/hr not_active Application Discontinuation
- 2002-10-15 HU HU0401647A patent/HUP0401647A3/hu unknown
2004
- 2004-04-15 ZA ZA200402858A patent/ZA200402858B/xx unknown
- 2004-04-16 ZA ZA200402910A patent/ZA200402910B/en unknown
- 2004-05-14 NO NO20041994A patent/NO20041994L/no not_active Application Discontinuation
- 2004-05-14 NO NO20041998A patent/NO20041998L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
HRP20040349A2 (en)	2005-06-30
CN1596249A (zh)	2005-03-16
JP2005527480A (ja)	2005-09-15
ZA200402910B (en)	2005-01-13
WO2003033481A1 (en)	2003-04-24
HUP0401647A2 (hu)	2004-11-29
WO2003033456A1 (en)	2003-04-24
EP1436247A1 (en)	2004-07-14
CA2463685A1 (en)	2003-04-24
US20110105748A1 (en)	2011-05-05
IL161429A0 (en)	2004-09-27
HUP0401647A3 (en)	2008-05-28
BR0213350A (pt)	2004-10-13
CN1589258A (zh)	2005-03-02
JP2005505617A (ja)	2005-02-24
ZA200402858B (en)	2005-01-12
US20050113368A1 (en)	2005-05-26
CA2463686A1 (en)	2003-04-24
NO20041998D0 (no)	2004-05-14
NO20041994L (no)	2004-05-14
NO20041998L (no)	2004-07-02
HUP0401649A3 (en)	2007-05-29
BR0213380A (pt)	2005-02-01
HRP20040350A2 (en)	2005-06-30
US7365064B2 (en)	2008-04-29
HUP0401649A2 (hu)	2004-11-29
IL161431A0 (en)	2004-09-27
EP1436268A1 (en)	2004-07-14
NZ532285A (en)	2005-11-25
PL369655A1 (pl)	2005-05-02

Legal Events

Date	Code	Title	Description
2009-12-31	REFS	Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)

Publication	Publication Date	Title
HUP0401649A3 (en)	2007-05-29	Benzoxazine and benzothiazine derivatives and pharmaceutical compositions containing them
IL158523A0 (en)	2004-05-12	Epothilone derivatives and pharmaceutical compositions containing the same
IL161616A0 (en)	2004-09-27	Indazolypyrrolotriazine derivatives and pharmaceutical compositions containing the same
IL157029A0 (en)	2004-02-08	Azaindoleoxoacetic piperazine derivatives and pharmaceutical compositions containing the same
IL158076A0 (en)	2004-03-28	Benzamidine derivatives and pharmaceutical compositions containing the same
IL158044A0 (en)	2004-03-28	Cyclopropylindole derivatives and pharmaceutical compositions containing the same
IL158300A0 (en)	2004-05-12	Bisarylimidazol derivatives and pharmaceutical compositions containing the same
IL159765A0 (en)	2004-06-20	Aryl substituted thiazolidinone derivatives and pharmaceutical compositions containing the same
IL152451A0 (en)	2003-05-29	2-chloro-2-nitrophenylcarboxamide derivatives and pharmaceutical compositions containing the same
HUP0301178A3 (en)	2009-08-28	Glucopyranosyloxybenzylbenzene derivatives and pharmaceutical compositions containing the same
IL153123A0 (en)	2003-06-24	N-ureidoheterocycloalkyl-piperidine derivatives and pharmaceutical compositions containing the same
IL156759A0 (en)	2004-02-08	Kits and pharmaceutical compositions containing epothilone derivatives
IL162548A0 (en)	2005-11-20	4-Oxoquinoline derivatives and pharmaceutical compositions containing the same
HUP0400467A3 (en)	2012-08-28	2-iminopyrrolidine derivatives, pharmaceutical compositions containing them and their use
IL160716A0 (en)	2004-08-31	Aryl-substituted pyridinecarboxamide derivatives and pharmaceutical compositions containing the same
IL150449A0 (en)	2002-12-01	Aniline derivatives and pharmaceutical compositions containing the same
IL156812A0 (en)	2004-02-08	Phthalazinone-piperidino derivatives and pharmaceutical compositions containing the same
IL166482A0 (en)	2006-01-15	Dihydropyrazolopyridine derivatives and pharmaceutical compositions containing the same
IL152094A0 (en)	2003-05-29	Ecteinascidin derivatives and pharmaceutical compositions containing the same
IL157740A0 (en)	2004-03-28	Heterocyclic derivatives and pharmaceutical compositions containing the same
IL156988A0 (en)	2004-02-08	Pharmaceutical compositions containing epothilone derivatives
IL158898A0 (en)	2004-05-12	PHARMACEUTICAL COMPOSITIONS CONTAINING APOMORPHINE, 6aR-(-)-N-PROPYL-NORAPOMORPHINE AND DERIVATIVES THEREOF
IL157128A0 (en)	2004-02-08	Pharmaceutical compositions containing epothilone derivatives
HUP0500024A3 (en)	2009-01-28	6-aminomorphinane derivatives, their use and pharmaceutical compositions containing them
IL160984A0 (en)	2004-08-31	Triazine derivatives and pharmaceutical compositions containing the same